3 results
There will be three formal interim analyses during the study. Interim Analysis 1 will occur at the end of Phase II when approximately 162 PFS events (defined as disease progression or death due to any cause, whichever occurs first) have been…
The objectives of the study are to fine-tune the Xres5 algorithm settings (for cine and fluoroscopy) to optimize the image quality (IQ) and assess and feasibility of using the improved IQ of Xres5 processing to reduce radiation dose or contrast…
Primary:• To Evaluate the safety and tolerability of tarlatamab • Determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D)Secondary:• Evaluate anti-tumor activity of tarlatamab as assessed by additional measures • Characterize…